2 years ago
PGNY
AnalystsScott SchoenhausScott Schoenhaus's Stock Forecasts
AnalystsScott Schoenhaus
Analyst Ranking
Bottom 2%
#5069 out of 5139 analysts
Average Return
-10.85%
Win Rate
36%40 out of 111
Risk vs Reward
Poor
Good
Scott Schoenhaus's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Lifemd IncLFMD | +91.05% | $6.26 | $11.96 | 2024-07-10 - 2025-07-10 | Strong Buy |
Albemarle CorpALB | +79.89% | $71.87 | $129.29 | 2025-07-13 - 2025-12-09 | Strong Buy |
R1 Rcm IncRCM | +57.10% | $6.90 | $10.84 | 2022-11-08 - 2023-11-08 | Strong Buy |
Benefitfocus IncBNFT | +55.94% | $6.65 | $10.37 | 2022-09-15 - 2022-11-08 | Strong Buy |
Abcellera Biologics IncABCL | +53.97% | $2.39 | $3.68 | 2025-04-15 - 2025-12-09 | Strong Buy |
Scott Schoenhaus Analyst Color
Get additional color on Scott Schoenhaus's coverage of popular stocks
2 years ago
RXRX
2 years ago
OMCL
3 years ago
VEEV
3 years ago
OMCL
3 years ago
PHR
Scott Schoenhaus's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Progyny IncPGNY | 5 | Strong Buy | $30.00 | +21.36% | Upgrades | a month ago |
Tenet Healthcare CorpTHC | 1 | Strong Buy | $225.00 | +11.39% | Maintains | 2 months ago |
Schrodinger IncSDGR | 6 | Strong Buy | $28.00 | +57.57% | Maintains | 2 months ago |
Phreesia IncPHR | 8 | Strong Buy | $32.00 | +107.39% | Maintains | 2 months ago |
Oddity Tech LtdODD | 4 | Strong Buy | $80.00 | +80.38% | Maintains | 2 months ago |
Healthequity IncHQY | 6 | Strong Buy | $120.00 | +28.67% | Maintains | 2 months ago |
Health Catalyst IncHCAT | 6 | Strong Buy | $4.00 | +53.26% | Maintains | 2 months ago |
Doximity IncDOCS | 5 | Strong Buy | $80.00 | +77.27% | Maintains | 2 months ago |
Certara IncCERT | 5 | Strong Buy | $16.00 | +74.48% | Maintains | 2 months ago |
Lifemd IncLFMD | 4 | Strong Buy | $12.00 | +230.58% | Maintains | 4 months ago |
Simulations Plus IncSLP | 4 | Strong Buy | $25.00 | +27.55% | Maintains | 5 months ago |
Hinge Health IncHNGE | 2 | Strong Buy | $60.00 | +21.29% | Maintains | 5 months ago |
Eastman Chemical CoEMN | 1 | Strong Buy | $93.00 | +51.94% | Maintains | 5 months ago |
Albemarle CorpALB | 1 | Strong Buy | $87.00 | -32.71% | Maintains | 5 months ago |
Abcellera Biologics IncABCL | 6 | Strong Buy | $10.00 | +171.74% | Maintains | 5 months ago |
Absci CorpABSI | 6 | Strong Buy | $9.00 | +155.68% | Maintains | 8 months ago |
Veeva Systems IncVEEV | 11 | Strong Buy | $255.00 | +9.91% | Maintains | a year ago |
Recursion Pharmaceuticals IncRXRX | 6 | Strong Buy | $10.00 | +109.64% | Maintains | a year ago |
Goodrx Holdings IncGDRX | 4 | Strong Buy | $6.00 | +122.22% | Maintains | a year ago |
Talkspace IncTALK | 1 | Strong Buy | $4.50 | N/A | Initiates Coverage On | a year ago |
Alight IncALIT | 6 | Strong Buy | $11.00 | N/A | Maintains | a year ago |
R1 Rcm IncRCM | 7 | Strong Buy | $17.00 | N/A | Maintains | 2 years ago |
Omnicell IncOMCL | 7 | Strong Buy | $75.00 | N/A | Maintains | 2 years ago |
Benefitfocus IncBNFT | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Veradigm IncMDRX | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Teladoc Health IncTDOC | 2 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Iqvia Holdings IncIQV | 1 | Strong Buy | $250.00 | N/A | Upgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.